MAGED1 and cancer: During oncogenic EMT, loss of E-cadherin downregulates ankyrin-G, enhancing NRAGE translocation to the nucleus, where the NRAGE-TBX2 complex can inhibit p14ARF gene expression to protect cancer cells against anoikis (32).